ARTICLE | Company News
Telios news
November 7, 1994 8:00 AM UTC
In the aftermath of the clinical setback of Argidene Gel to treat diabetic foot ulcers, TLIO (San Diego) will reduce its work force to 80 from 138. TLIO retained positions in research, product development, manufacturing, and clinical and regulatory affairs. ...